A Real-World Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Patients Receiving Dupilumab Therapy, with Atopic Dermatitis Control Tool in Gulf Countries
عنوان الدراسة
A Real-World Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Patients Receiving Dupilumab Therapy, with Atopic Dermatitis Control Tool in Gulf Countries
داعم الدراسة
Sanofi
دواء الدراسة
Dupilumab (Dupixent)
رقم بروتوكول الدراسة
OBS17399
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz University Hospital (Jeddah),Saudi Airlines Medical Service Center,Dr. Erfan & Bagedo General Hospital (Jeddah),Specialized Medical Center (Riyadh),JC Clinics Complex – Jeddah,Saudi German Hospital (Jeddah),Sulaiman Al Habib Hospital - Al Khobar,King Fahad Medical City (Riyadh),King Faisal General Hospital (Makkah),Al Mana Hospital,King Abdul Aziz Hospital (Makkah)
مرحلة الدراسة
4
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.